3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
2
Status
Terminated
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
2
Lymphoid
2
Conditions
Sarcoma
3
Vomiting
2
Neoplasms
2
Nausea
2
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia
2
Hodgkin Disease
2
Thalassemia
1
Teratoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Osteosarcoma
1
Neoplasms, Germ Cell and Embryonal
1
Medulloblastoma
1
Lymphoma, Follicular
1
Hepatoblastoma
1
Hematologic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Interventions
fludarabine phosphate
10
Cyclophosphamide
10
Peripheral Blood Stem Cell Transplantation
9
Cyclosporine
7
Mycophenolic Acid
6
Filgrastim
6
Antilymphocyte Serum
6
Whole-Body Irradiation
5
Busulfan
5
Radiotherapy
4
Psychiatric Rehabilitation
4
Cytarabine
4
Methylprednisolone
3
Methotrexate
3
Melphalan
3
Cord Blood Stem Cell Transplantation
3
Aprepitant
3
thymoglobulin
2
Therapeutics
2
Tacrolimus
2
Polymerase Chain Reaction
2
Ondansetron
2
Mesna
2
Flow Cytometry
2
Dexamethasone
2
Calcium Dobesilate
2
Analgesia
2
sargramostim
1
plerixafor
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Myeloproliferative Disorders
×
Mesna
×
Clear all
NCT00578461
2016-04-22
REGKINE
Baylor College of Medicine
Phase NA
Terminated
26 enrolled
7 charts
NCT00578539
2016-04-22
REGALE
Baylor College of Medicine
Phase NA
Terminated
24 enrolled
7 charts